cefotiam has been researched along with Leucocythaemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kageyama, S; Kamio, N; Kataoka, Y; Katayama, N; Koh, T; Minami, N; Ono, T; Ota, C; Tanaka, I; Uno, N | 1 |
| Maekawa, T; Murakami, H; Nemoto, K; Okamoto, K; Omine, M; Tsuchiya, J | 1 |
| Nossek, L; Seng, P; Spors, S | 1 |
| Ishiyama, T; Miyayama, T; Nomoto, H; Shiokawa, Y; Sugaya, N; Sugimoto, M; Wakabayashi, Y | 1 |
4 other study(ies) available for cefotiam and Leucocythaemia
| Article | Year |
|---|---|
[Clinical investigation of cefotiam in combination with aminoglycoside or (and) penicillin against complicated infections with hematopoietic disorders].
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cefotiam; Drug Therapy, Combination; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Penicillins; Pneumonia; Sepsis | 1984 |
[Clinical investigation of cefotiam against infections complicated by acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cefotiam; Child; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged | 1982 |
[Cefotiam in infections of granulocytopenic tumor patients].
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Bacterial Infections; Cefotaxime; Cefotiam; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged | 1982 |
[Clinical investigation of combined therapy (cefotiam, sulbenicillin and cefsulodin) against infections complicated by acute leukemia].
Topics: Acute Disease; Adult; Bacterial Infections; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Penicillin G; Sulbenicillin | 1983 |